Yinfeng Cryogenic Medical Technology Co., Ltd. was listed on the list of "Innovative Small and Medium-sized Enterprises in Shandong Province in 2022".
Release time:
2022-12-31
On December 30, 2022, the Shandong Provincial Department of Industry and Information Technology announced the list of "Shandong Province 2022 Innovative Small and Medium-sized Enterprises", and Yinfeng Cryogenic Medical Technology Co., Ltd. (hereinafter referred to as "Yinfeng Cryological") won this honor.
The selection of "Shandong Province 2022 Innovative Small and Medium-sized Enterprises" aims to adhere to the improvement of the innovation ability and professional level of small and medium-sized enterprises, actively carry out the gradient cultivation of high-quality small and medium-sized enterprises, and continuously increase the support for various high-quality small and medium-sized enterprises.
In recent years, cryogenic biomedicine, as a forward-looking field of human medical research, is inseparable from the joint efforts of scientific research teams from all parties. Recently, the second expert committee of Yinfeng Cryogenic Medicine was formally established, bringing together 22 international and domestic experts and scholars from cryogenic biomedicine, cryopreservation of human tissues and organs, clinical scientific research, biomaterials science and other related fields, to carry out technology research and development and transformation of clinical achievements in the field of cryogenic biomedicine, build an academic exchange and achievement sharing platform for the global cryogenic biomedical research team, integrate international and domestic scientific research and academic forces in multiple fields, and build a systematic cryogenic biomedical research system. Contribute China's strength to the development of international cryogenic medicine.
Latest developments
Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.
According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).
Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.
Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.
On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
